# Yair Lotan

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/yair-lotan/

## Facts

| Field | Value |
| --- | --- |
| Citations | 58,124 |
| Field | Bladder and Urothelial Cancer Treatments |
| h-index | 115 |
| i10-index | 593 |
| Last Known Institution | Southwestern Medical Center |
| OpenAlex ID | https://openalex.org/A5041923034 |
| ORCID iD | https://orcid.org/0000-0001-5692-2723 |
| Works | 1,519 |

## Researcher papers

- [Epidemiology of stone disease across the world](https://scholariq.org/papers/epidemiology-of-stone-disease-across-the-world/)
- [BAP1 loss defines a new class of renal cell carcinoma](https://scholariq.org/papers/bap1-loss-defines-a-new-class-of-renal-cell-carcinoma/)
- [Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer](https://scholariq.org/papers/multicenter-assessment-of-neoadjuvant-chemotherapy-for-muscle-invasive-bladder/)
- [A Validated Tumorgraft Model Reveals Activity of Dovitinib Against Renal Cell Carcinoma](https://scholariq.org/papers/a-validated-tumorgraft-model-reveals-activity-of-dovitinib-against-renal-cell/)
- [Prediction of Cancer Specific Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: Development of an Optimized Postoperative Nomogram Using Decision Curve Analysis](https://scholariq.org/papers/prediction-of-cancer-specific-survival-after-radical-nephroureterectomy-for/)
- [NOMOGRAMS INCLUDING NUCLEAR MATRIX PROTEIN 22 FOR PREDICTION OF DISEASE RECURRENCE AND PROGRESSION IN PATIENTS WITH Ta, T1 OR CIS TRANSITIONAL CELL CARCINOMA OF THE BLADDER](https://scholariq.org/papers/nomograms-including-nuclear-matrix-protein-22-for-prediction-of-disease/)
- [Conditional Survival After Radical Cystectomy for Bladder Cancer: Evidence for a Patient Changing Risk Profile over Time](https://scholariq.org/papers/conditional-survival-after-radical-cystectomy-for-bladder-cancer-evidence-for-a/)

## Researcher topics

- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [Urinary and Genital Oncology Studies](https://scholariq.org/topics/urinary-and-genital-oncology-studies-2/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.